A pilot study of CS-1008, a humanized monoclonal antibod

Skubitz, Keith (PI)

Medicine - Hematology, Oncology, Transplant

Project: Research project

Description

A pilot study of CS-1008, a humanized monoclonal antibody targeting death receptor 5, alone or in combination with imatinib mesylate or sunitinib

Status	Finished
Effective start/end date	9/25/07 → 12/31/10

Funding

Daiichi Sankyo Company, Limited